Piretanide
 | |
| Clinical data | |
|---|---|
| Trade names | Arelix, Eurelix, Tauliz, others |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | ~90%[2] |
| Protein binding | 96% |
| Metabolism | not identified |
| Excretion | Urine (60%), feces (40%) |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.054.394 |
| Chemical and physical data | |
| Formula | C17H18N2O5S |
| Molar mass | 362.40 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
Piretanide is a loop diuretic[3] compound by using a then-new method for introducing cyclic amine residues in an aromatic nucleus in the presence of other aromatically bonded functional groups. Studies of piretanide in rats and dogs in comparison with other high-ceiling diuretics such as furosemide and bumetanide found a more suitable dose/response rate (regression line) and a more favourable sodium/potassium excretion ratio. These findings led eventually to studies in man and finally to the introduction as a saluretic and antihypertensive[4] medication in Germany, France, Italy and other countries.
It was made in 1973, patented in 1974, and approved for medical use in 1981.[5]
Brand names
[edit]Brand names include Arelix, Eurelix, Tauliz.
References
[edit]- ^ "List of nationally authorised medicinal products : Active substance: piretanide: Procedure no.: PSUSA/00002433/202110" (PDF). Ema.europa.eu. Retrieved 28 June 2022.
- ^ Mutschler E (1995). Greger RF, Knauf H, Mutschler E (eds.). Diuretics. Handbook of Experimental Pharmacology. Vol. 117. Berlin, Heidelberg: Springer Science & Business Media. p. 517. ISBN 978-3642795657.
- ^ Musini VM, Rezapour P, Wright JM, Bassett K, Jauca CD (May 2015). "Blood pressure-lowering efficacy of loop diuretics for primary hypertension". The Cochrane Database of Systematic Reviews. 2015 (5): CD003825. doi:10.1002/14651858.CD003825.pub4. PMC 7156893. PMID 26000442.
- ^ Haberfeld H, ed. (2009). Austria-Codex (in German) (2009/2010 ed.). Vienna: Österreichischer Apothekerverlag. ISBN 978-3-85200-196-8.
- ^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 458. ISBN 9783527607495.
Further reading
[edit]- Merkel W, Bormann D, Mania D, Muschaweck R, Hropot M (1976). "Piretanide (HOE118): A new high-ceiling sali-diuretic". European Journal of Medicinal Chemistry. 11: 399.
- Merkel W, Mania D, Bormann D (1979). "Selektive Reduktion von Imiden mit funktionellen Gruppen" [Selective reduction of imides in the presence of other function groups]. Liebigs Annalen der Chemie (in German). 1979 (4): 461–9. doi:10.1002/jlac.197919790406.
 | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |